INTERNATIONAL PATENT: WUXI BIOLOGICS (SHANGHAI) CO., LTD., WUXI BIOLOGICS IRELAND LIMITED FILES APPLICATION FOR "COMBINATION OF CHIMERIC ANTIGEN RECEPTOR AND DAP10 IN CELL THERAPY"

GENEVA, July 7 -- WUXI BIOLOGICS (SHANGHAI) CO., LTD. (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131), WUXI BIOLOGICS IRELAND LIMITED (Mullagharlin, Dundalk, Co Louth A91 X56F) filed a patent application (PCT/CN2024/142173) for "COMBINATION OF CHIMERIC ANTIGEN RECEPTOR AND DAP10 IN CELL THERAPY" on Dec 25, 2024. With publication no. WO/2025/140265, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CUI, Qian (No. 299 Fute Zhong RoadPudong New Area, Shanghai 200131), WANG, Hong (No. 299 Fute Zhong RoadPudong New Are...